|
AXSM Axsome Therapeutics Inc 1579428 |
| Balance Sheet |
|
Current Assets
|
$656,569,000.00 |
|
Assets
|
$761,447,000.00 |
|
Current Liabilities
|
$460,446,000.00 |
|
Liabilities
|
$678,143,000.00 |
|
Equity
|
$83,304,000.00 |
|
Shares Out
|
52299889.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-53,652,000.00 |
|
Investing Cash Flow
|
$-571,000.00 |
| Market Analysis |
Market Cap
|
$10,879,945,908.67 |
|
Price
|
$208.03 |
|
BVPS
|
1.59 |
|
PB
|
130.84 |
|
EPS
|
-0.99 |
|
PS
|
12.46 |
|
FCF
|
$-54,223,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:10 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.56 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-04 |
-1.26 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-04 |
-0.97 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-0.94 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AXSM documents filed with the SEC.
AXSM Filings
Clear
